Videos: Early Detection of Metastatic Prostate Cancer
This site has a number of videos on early detection of metastatic prostate cancer. View them here.
Videos: Early Detection of Metastatic Prostate Cancer Read More »
VIDEO: Dr. Sharon Sharir, “Decision-making and patient-doctor communication regarding prostate cancer”
January 2014 Scotiabank Awareness Night “Decision-making and patient-doctor communication regarding prostate cancer” Dr. Sharon Sharir MD, MPH, FRCSC Division of Urology, Humber River Regional Hospital Assistant Professor, Dept. of Surgery, University of Toronto CLICK ON THE ARROW TO START THE VIDEO Click here for The Complete Presentation 60:48 minutes \ The compete presentation is available in 6 parts. Click here for Presentation Part 1 Click here for Presentation Part 2 Click here for Presentation Part 3 Click here for Presentation Part 4 Click here for Presentation Part 5 Click here for Presentation Part 6 Click here for Winston Klass Thanks
3D Mapping Biopsy Finds 3x Prostate Cancer of Ultrasound-Guided Biopsy
Ultrasound-guided biopsies miss prostate cancers that are detected by the slightly more expensive and slightly more invasive 3D mapping biopsies. For example, in a 2006 study of 180 men diagnosed with early stage prostate cancer via ultrasound-guided biopsy, nearly a quarter were upgraded to a more clinically significant stage of disease after 3D mapping biopsy found pockets of cancer the first technique had missed. Now, a University of Colorado Cancer Center study reports the locations of these most-missed pockets of prostate cancer. Read the article.
3D Mapping Biopsy Finds 3x Prostate Cancer of Ultrasound-Guided Biopsy Read More »
Gleason 6 Prostate Cancer: Serious Malignancy or Toothless Lion?
Here are 2 articles on Gleason 6 Prostate Cancer: Gleason 6 Prostate Cancer: Serious Malignancy or Toothless Lion? – See More and a follow-up: Gleason 6 Cancer Is Still Cancer – See More
Gleason 6 Prostate Cancer: Serious Malignancy or Toothless Lion? Read More »
Invasive tests for prostate cancer are failing to spot the disease
Thousands of men forced to have painful biopsies * Most are still being put through outdated tests which are not reliable * Worryingly, many get a negative result even though they have cancer * They should be given an MRI scan that can rule the disease out Read the article.
Invasive tests for prostate cancer are failing to spot the disease Read More »
Protein in prostate biopsies signals increased cancer risk
Researchers from Weill Cornell Medical College have shown that the presence of a particular protein in biopsied prostate tissue substantially increases the likelihood that cancer will develop in that organ. The discovery will likely help physicians decide how closely to monitor men potentially at risk for the cancer—among the most confusing and controversial dilemmas in health care. Read the article.
Protein in prostate biopsies signals increased cancer risk Read More »
Men (aged 40-49 years) with a single baseline PSA below 1.0 have a very low long-term risk of prostate cancer
Men (aged 40-49 years) with a single baseline prostate-specific antigen below 1.0 ng/mL have a very low long-term risk of prostate cancer: Results from a prospectively screened population cohort – Abstract [www.urotoday.com] Published on 19 November 2013 OBJECTIVE: To study the use of a baseline prostate-specific antigen (PSA) and digital rectal examination in men (aged 40-49 years) in predicting long-term prostate cancer risk in a prospectively followed, representative population cohort. PATIENTS AND METHODS: Since 1990, a random sample of men in Olmsted County (aged 40-49 years) has been followed up prospectively (n = 268), with biennial visits, including a urologic
Half of medical reporting ‘is subject to spin’
A study that you probably won’t be reading in your daily paper or favourite news website anytime soon casts serious doubts on the reliability of mainstream medical and health journalism. The study found that 51% of news items reporting on medical trials – specifically on randomised controlled trials (RCTs), which are seen as the gold standard in judging whether a treatment is effective or safe – were subject to “spin”. Read the article.
Half of medical reporting ‘is subject to spin’ Read More »
New prostate test that identifies less harmful tumours that do not need to be removed immediately will spare men from needless surgery
A new test for prostate cancer could spare thousands of men needless treatment which leaves them with debilitating side effects, researchers claim. The test can accurately pinpoint the less harmful tumours which do not have to be immediately removed by surgery or radiotherapy. Read more: http://www.dailymail.co.uk/health/article-2487483/New-prostate-test-identifies-harmful-tumours-need-removed-immediately-spare-men-needless-surgery.html#ixzz2lIfSTsd7
VIDEO: Dr. Danny Vesprini, “Prostate Cancer – identifying men at high risk before it’s too late”
September 2013 Scotiabank Awareness Night “Prostate Cancer – identifying men at high risk before it’s too late” Dr. Danny Vesprini, MD, MSc, BSc, FRCPC Assistant Professor Department of Radiation Oncology, University of Toronto Staff Radiation Oncologist, Sunnybrook Odette Cancer Centre Dr. Vesprini discusses the current and upcoming strategies for screening and ultimately treating men who are at increased risk of developing aggressive prostate cancer, including men with a strong family history, men with a known genetic trait that causes aggressive disease, and men of Western African/Caribbean descent. CLICK ON THE ARROW TO START THE VIDEO Click here for Complete Video Introduction by